One-Year Impact of Kidney Transplantation on Cardiac Abnormalities and Blood Pressure in Hemodialysis Patients.
Hideki FujiiShuhei WatanabeKeiji KonoKentaro WatanabeShunsuke GotoTakeshi IshimuraMasato FujisawaShinichi NishiPublished in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2019)
Cardiac abnormalities, including left ventricular hypertrophy and systolic dysfunction, are frequently observed among patients with CKD, including kidney transplant recipients; they are closely linked to cardiovascular disease and mortality. Although several studies have been performed for elucidating changes and mechanisms of cardiac abnormalities after kidney transplantation, details remain unclear. This study included 43 consecutive patients who underwent HD and received kidney transplantation between 2008 and 2012 at our institution. All subjects underwent echocardiography before and 1 year after kidney transplantation. One year after kidney transplantation, left ventricular mass index, cardiac chamber sizes, BP, and the number of antihypertensive agents were reduced. Although the percentage of patients with concentric hypertrophy did not change, the percentage of those with eccentric hypertrophy significantly decreased after kidney transplantation. Volume reduction due to the recovery of kidney function may be primarily attributed to the improvement of cardiac abnormalities, including left ventricular hypertrophy.
Keyphrases
- left ventricular
- kidney transplantation
- blood pressure
- hypertrophic cardiomyopathy
- heart failure
- cardiac resynchronization therapy
- acute myocardial infarction
- left atrial
- cardiovascular disease
- aortic stenosis
- mitral valve
- end stage renal disease
- chronic kidney disease
- cardiovascular events
- computed tomography
- oxidative stress
- peritoneal dialysis
- type diabetes
- atrial fibrillation
- coronary artery disease
- hypertensive patients
- glycemic control